Colossal Biosciences Inc. — Form D/A
Colossal Biosciences Inc. of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2024-07-23. The offering totals $173.8M, of which $162.6M was reported sold. Industry: Other.
Offering
- Filed: 2024-07-23
- Form: D/A
- Accession: 0001964433-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $173.8M
- Amount sold: $162.6M
- Remaining: $11.2M
- Investors: 27
- Date of first sale: 2023-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473211
Issuer
- Name: Colossal Biosciences Inc.
- CIK: 0001964433
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1401 LAVACA STREET, AUSTIN, TX, 78701
- Phone: 512-576-0777
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Brian Beard | Director | Austin, TX |
| Tom Chi | Director | Austin, TX |
| Benjamin Lamm | Director | Austin, TX |
| Brian Beard | Executive Officer | Austin, TX |
| Benjamin Lamm | Executive Officer | Austin, TX |
Other filings by this issuer (1)
More